HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara.

Abstract
Vaccinia virus vectors are attractive tools to direct high level protein synthesis in mammalian cells. In one of the most efficient strategies developed so far, the gene to be expressed is positioned downstream of a bacteriophage T7 promoter within the vaccinia genome and transcribed by the T7 RNA polymerase, also encoded by the vaccinia virus genome. Tight regulation of transcription and efficient translation are ensured by control elements of the Escherichia coli lactose operon and the encephalomyocarditis virus leader sequence, respectively. We have integrated such a stringently controlled expression system, previously used successfully in a standard vaccinia virus backbone, into the modified vaccinia virus Ankara strain (MVA). In this manner, proteins of interest can be produced in mammalian cells under standard laboratory conditions because of the inherent safety of the MVA strain. Using this system for expression of beta-galactosidase, about 15 mg protein could be produced from 10(8) BHK21 cells over a 24-h period, a value 4-fold higher than the amount produced from an identical expression system based on a standard vaccinia virus strain. In another application, we employed the MVA vector to produce human tubulin tyrosine ligase and demonstrate that this protein becomes a major cellular protein upon induction conditions and displays its characteristic enzymatic activity. The MVA vector should prove useful for many other applications in which mammalian cells are required for protein production.
AuthorsMatthias Hebben, Jan Brants, Catherine Birck, Jean-Pierre Samama, Bohdan Wasylyk, Danièle Spehner, Karine Pradeau, Arban Domi, Bernard Moss, Patrick Schultz, Robert Drillien
JournalProtein expression and purification (Protein Expr Purif) Vol. 56 Issue 2 Pg. 269-78 (Dec 2007) ISSN: 1046-5928 [Print] United States
PMID17892951 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Recombinant Proteins
  • Ligases
Topics
  • Animals
  • Cells, Cultured
  • Cricetinae
  • Gene Expression Regulation, Viral
  • Genes, Reporter
  • Genetic Vectors
  • Humans
  • Kinetics
  • Ligases (metabolism)
  • Recombinant Proteins (biosynthesis, genetics)
  • Vaccinia virus (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: